Collamat, Baby Boy .

HRN: 28-92-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
AMPICILLIN 250MG (VIAL)
05/03/2026
05/09/2026
IVT
165mg
Q12H
NAMF (Maternal UTI; Maternal URTI)
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Prophylaxis    Compliance to guidelines: